ALIGOS THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$4.80
-4.57%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-12.7%
3 months
+4.3%
6 months
-21.2%
1 year
-41.5%
Year to date
-48.5%
52-week range
$4.08 – $13.30
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$59.9M
P/E
-0.8
P/B
1.9
P/S
1.9
Revenue
$31.52M
Net income
-$75.96M
Diluted EPS
-7.4
Gross margin
100.00%
Net margin
-241.00%
Return on equity
-160.70%
Total debt
$3.5M
Cash
$30.42M
Free cash flow
-$94.52M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $27.78M | -$1.5M | 100.00% | -5.40% | -$24.95M |
| Mar 31, 2026 | $2.83M | -$23.04M | 100.00% | -814.10% | -$23.2M |
| Dec 31, 2025 | $169K | -$19.88M | 100.00% | -11763.90% | -$21.84M |
| Sep 30, 2025 | $741K | -$31.54M | 100.00% | -4256.00% | -$24.54M |
| Jun 30, 2025 | $965K | -$15.86M | 100.00% | -1643.80% | -$15.61M |
| Mar 31, 2025 | $311K | $43.09M | 100.00% | 13854.70% | -$20.95M |
| Dec 31, 2024 | $629K | -$82.15M | 100.00% | -13060.40% | -$18.43M |
| Sep 30, 2024 | $1.27M | -$19.26M | 100.00% | -1517.70% | -$20.13M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ALGS news
All market newsNo ticker-linked stories are in the current archive.